For the month of December 2018, Cadence Capital Limited returned a negative gross performance of 5.9% compared to a decrease in the All Ordinaries Accumulation Index of 0.5%. For the past month, the largest detractors from performance were ARQ Group Ltd, Emeco Holdings Ltd, Teva Pharmaceutical Industries Ltd, Nine Entertainment and Ausdrill Ltd. The largest contributors to performance were Liquified Natural Gas Ltd and Longtable Group Ltd. At 31 December 2018 the Company was 58% invested (42% cash).
The Company intends to release its half year webcast over the coming week. In this webcast we will discuss the company’s performance over the past 6 months, the current top positions in the portfolio, and the outlook for 2019.
Fund NTA
Fund Performance
* Gross Performance: before Management and Performance Fees
CDM Share Price and Option Returns plus Dividends & Franking
Fully Franked Dividends Declared Since Listing
Historic Portfolio Exposure
Portfolio Sector Analysis
Top Portfolio Position
Recent News
We encourage you to visit our 52 books you should read before buying your next stock page on our website. We have compiled a list of books/ documentaries that have influenced our investment style or helped provide insight into the investment process. To view all previous Cadence webcasts and press articles, please visit the Media Section of the website.
We welcome any of your friends or colleagues that you feel may benefit from our monthly Cadence Capital Limited Newsletter. Please click here to refer a friend by supplying their name and email address.
